Antihypertensive Therapy in Pre-Eclampsia: Effects of Plasma from Nonresponsive Patients on Endothelial Gene Expression

References

• Powe CE , LevineRJ , KarumanchiSA . Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease . Circulation123 ( 24 ), 2856 – 2869 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Mackenzie RM , SandrimVC , CartyDMet al. Endothelial FOS expression and pre-eclampsia . BJOG119 ( 13 ), 1564 – 1571 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Sankaralingam S , LaluMM , XuY , DavidgeST . Effect of peroxynitrite scavenging on endothelial cells stimulated by plasma from women with preeclampsia: a proteomic approach . Hypertens. Pregnancy29 ( 4 ), 419 – 428 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Luizon MR , PaleiAC , SandrimVCet al. Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy . Pharmacogenomics J.14 ( 6 ), 535 – 541 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Luizon MR , SandrimVC . Pharmacogenomic approaches that may guide preeclampsia therapy . Pharmacogenomics14 ( 6 ), 591 – 593 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sandrim VC , PaleiAC , LuizonMR , Izidoro-ToledoTC , CavalliRC , Tanus-SantosJE . eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension . Pharmacogenomics J.10 ( 1 ), 40 – 45 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy . Am. J. Obstet. Gynecol.183 ( 1 ), S1 – S22 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• GeneGlobe Data Analysis Center – QIAGEN . www.qiagen.com/br/shop/analytics-software/geneglobe-data-analysis-center/ .
   Google Scholar
• Kodavanti UP , ThomasRF , LedbetterADet al. Diesel exhaust induced pulmonary and cardiovascular impairment: the role of hypertension intervention . Toxicol. Appl. Pharmacol.268 ( 2 ), 232 – 240 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Wilson RM , De SilvaDS , SatoK , IzumiyaY , SamF . Effects of fixed-dose isosorbide dinitrate/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure . Hypertension54 ( 3 ), 583 – 590 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Ishii N , MatsumuraT , KinoshitaHet al. Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice . Arterioscler. Thromb. Vasc. Biol.30 ( 8 ), 1598 – 1605 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Matsumori A , NishioR , NoseY . Calcium channel blockers differentially modulate cytokine production by peripheral blood mononuclear cells . Circ. J.74 ( 3 ), 567 – 571 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Shih CY , LinMH , FanHC , ChenFC , ChouTC . Mechanisms of antiplatelet activity of nifedipine: role of peroxisome proliferator-activated receptor-beta-gamma-dependent processes . J. Hypertens.32 ( 1 ), 181 – 192 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Ding Y , VaziriND . Nifedipine and diltiazem but not verapamil up-regulate endothelial nitric-oxide synthase expression . J. Pharmacol. Exp. Ther.292 ( 2 ), 606 – 609 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Dong B , MatsumuraF . Roles of cytosolic phospholipase A2 and Src kinase in the early action of 2,3,7,8-tetrachlorodibenzo-p-dioxin through a nongenomic pathway in MCF10A cells . Mol. Pharmacol.74 ( 1 ), 255 – 263 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Matsui T , YamagishiS , TakeuchiM , UedaS , FukamiK , OkudaS . Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation . Biochem. Biophys. Res. Commun.385 ( 2 ), 269 – 272 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Miura S , FujinoM , MatsuoY , TanigawaH , SakuK . Nifedipine-induced vascular endothelial growth factor secretion from coronary smooth muscle cells promotes endothelial tube formation via the kinase insert domain-containing receptor/fetal liver kinase-1/NO pathway . Hypertens. Res.28 ( 2 ), 147 – 153 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• HUGO Gene Nomenclature Committee . http://www.genenames.org/ .
   Google Scholar
• Maebayashi Asanuma A , YamamotoT , AzumaHet al. Expression of placenta growth factor, soluble fms-like tyrosine kinase-1, metal-responsive transcription factor-1, heme oxygenase 1 and hypoxia inducible factor-1alpha mRNAs in pre-eclampsia placenta and the effect of pre-eclampsia sera on their expression of choriocarcinoma cells . J. Obstet. Gynaecol. Res.40 ( 10 ), 2095 – 2103 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Spranger RM , HartnerA , SchildRLet al. Leptin expression in primary trophoblast cells in response to incubation with the serum of preeclamptic women . Hyperten. Pregnancy27 ( 3 ), 267 – 277 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Donker RB , AsgeirsdottirSA , GerbensFet al. Plasma factors in severe early-onset preeclampsia do not substantially alter endothelial gene expression in vitro . J. Soc. Gynecol. Invest.12 ( 2 ), 98 – 106 ( 2005 ).
   PubMedGoogle Scholar
• Calicchio R , BuffatC , MathieuJRet al. Preeclamptic plasma induces transcription modifications involving the AP-1 transcriptional regulator JDP2 in endothelial cells . Am. J. Pathol.183 ( 6 ), 1993 – 2006 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kronborg CS , KnudsenUB , MartensenPM . Differential regulation of the interferon induced gene ISG12A by serum from healthy and preeclamptic pregnancies . Cytokine42 ( 1 ), 105 – 112 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Anteby EY , Natanson-YaronS , HamaniYet al. Fibroblast growth factor-10 and fibroblast growth factor receptors 1–4: expression and peptide localization in human decidua and placenta . Eur. J. Obstet. Gynecol. Reprod. Biol.119 ( 1 ), 27 – 35 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Sandrim VC , LuizonMR , PaleiAC , Tanus-SantosJE , CavalliRC . Circulating microRNA expression profiles in pre-eclampsia: evidence of increased miR-885-5p levels . BJOG doi:10.1111/1471-0528.13903 ( 2016 ) ( Epub ahead of print ).
   PubMed Web of Science ®Google Scholar
• Cooper-Dehoff RM , JohnsonJA . Hypertension pharmacogenomics: in search of personalized treatment approaches . Nat. Rev. Nephrol.12 ( 2 ), 110 – 122 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Williams PJ , MorganL . The role of genetics in pre-eclampsia and potential pharmacogenomic interventions . Pharmgenomics Pers. Med.5 , 37 – 51 ( 2012 ).
   PubMedGoogle Scholar